Dismissal of Infringement Claim Reversed Because Additional Analysis and Proceedings were Needed to Arrive at a Proper Claim Construction

In Utto Inc. v. Metrotech Corp., [2023-1435](October 18, 2024), the Federal Circuit we vacated in part the dismissal of Utto’s claim for infringement of U.S. Patent No. 9,086,441, which describes and claims methods for detecting and identifying underground utility lines, and affirmed the dismissal of Utto’s claim for tortious interference with prospective economic advantage.

The court construed the claim language “group of buried asset data points” in both the “receiving” and “generating” limitations of claim 1 to require “two or more” buried asset data points for each buried asset, adopting that construction as reflecting the “ordinary and customary meaning.” The court acknowledged that the specification in two places refers to “one or more buried asset data points” for a given buried asset, but the court said that those references to the singular occur “[o]nly twice” and “neither supports the ordinary reading of the claim language itself.”

On appeal, Utto argued that a district court may never engage in claim construction in deciding a motion to dismiss.  The Federal Circuit did not agree that claim construction is categorically forbidden at the Rule 12(b)(6) stage of a case. But the Federal Circuit agreed that, in this case, additional analysis and proceedings are needed to arrive at a proper construction.  UTTO pointed to several pieces of extrinsic evidence that it sought to present at further proceedings, including encyclopedia articles on “group theory” and “group,” the testimony of its founder, and the testimony and report of an expert.  The Federal Circuit itself saw “several issues relevant to a proper claim construction that would significantly benefit from fuller exploration by the parties and the district court.

The Federal Circuit noted that the claim language does not appear to be the kind of language that has so “plain” a univocal meaning that to give it a contrary construction would require meeting the high standard of redefinition or clear disclaimer.  Relatedly, the Federal Circuit noted, to the extent that “group of [plural term]” shares the character of plurals, the proper meaning is presumptive, but only presumptive—the specification not having to rise to the level of redefinition or disclaimer to overcome the presumed “two or more” meaning.

The Federal Circuit vacated the district court’s dismissal of UTTO’s infringement claim and remand for further claim construction proceedings. We do not here decide whether the district court’s claim construction is correct.

October 14, 2024

Before modern sensibilities, Christopher Columbus’ achievement in sailing across the Atlantic Ocean in 1492 was celebrated, including in the U.S. Patent Collection. U.S. Patent No. 21448 was issued on a design for a Buckle (with the image of Christopher Columbus):

U.S. Patent No. D21573 issued on a Badge featuring the image of Christopher Columbus:

U.S. Patent No. D221,221 issued on a Spoon featuring Columbus’ ship:

U.S. Patent No. D21255 on the design of a Medal featuring the image of Christopher Columbus:

U.S. Patent No. 418455 issued on an Educational Globe that tracks that voyage of Columbus.

October 11, 2024

On October 11, 1938, Games Slayter received U.S. Patent No. 2,133,235, on a Method and Apparatus for Making Glass Wool:

Slayter was the driving force behind the development of fiber glass for Owens-Illinois. A few years later Dale Kleist, a researcher working under Slayter, discovered an improvement to the process when he accidently blasted the fiber with air, which after some refinement resulted in U.S. Patent No. 2,121,802:

October 9, 2024

On October 9, 1855, Isaac M. Singer received U.S. Patent No. 13661 on a Sewing Machine:

Of course, Singers’ was not the first patent on a sewing machine. Elias Howe is generally regarded as the first inventor of the sewing machine, and he received U.S. Patent No. 4750 on September 10, 1846:

Howe also received U.S. Patent Nos. 16,436 on January 20, 1857, 17679 on June 30, 1857, and 21158 on August 24, 1858. However, rather than making and selling machines himself, Howe made his fortune by suing those who he felt had infringed on his patents.

Dismissal of Infringement Claims Reversed; Complaint Merely Must Place the Alleged Infringer on Notice of What Activity is being Accused of infringement. 

In Alexsam, Inc. v. AETNA, Inc., [2022-2036] (October 8, 2024), the Federal Circuit vacated and remanded portions of the district court’s dismissal of AlexSam’s claim for infringement of U.S. Patent No. 6,000,608.   The ’608 patent is entitled “Multifunction Card System” is directed to “a debit/credit card capable of performing a plurality of functions” and a “processing center which can manage such a multifunction card system.”

The district court found that AlexSam could not prevail on its claims based on the Mastercard Products because Aetna had an express license via the License Agreement to market those products. The court further concluded that AlexSam failed to state a claim of direct infringement based on the VISA Products because only third-party customers, and not Aetna itself, could have directly infringed. It appeared to the district court that AlexSam’s accusations were largely targeted at Aetna’s subsidiaries, who were not defendants, and that “AlexSam fail[ed] to allege control or direction by Aetna which would warrant disregarding the corporate form.”

On appeal, AlexSam raised two specific challenges to the district court’s conclusions: (i) that Aetna’s Mastercard Products are licensed and, therefore, cannot directly or indirectly infringe claims 32 and 33 of the ’608 patent, and (ii) that it is implausible to believe that Aetna itself “makes” or “uses” the VISA Products.

The Federal Circuit agreed with AlexSam that the district court erred by resolving the Mastercard licensing issues “on the limited information provided” in the Second Amended Complaint, its attachments, and the motion to dismiss briefing.   The Federal Circuit said that not only was the scope of the license narrower than the district court seems to have un-derstood, but there were also open issues remaining that need to be resolved before the impact of the license on AlexSam’s allegations can be fully assessed.

On the infringement allegations, the Federal Circuit said the district court erred by concluding that AlexSam failed to allege a plausible claim of direct infringement by Aetna’s making and using the VISA Products.  The Federal Circuit said that a plaintiff is not required to plead infringement on an element-by-element basis.  Instead, it is enough that a complaint place the alleged infringer on notice of what activity is being accused of infringement. 

October 8, 2024

On October 8, 1940, David C. Rockola received U.S. Patent No. D122,946 on a Cabinet for Remote Control Apparatus:

This was not the first patent by this prolific inventor, that was U.S. Patent No. USD81021 that issued more than ten years earlier in 1930, and it was far from the last, that was U.S. Patent No. US 3771691 that issued more than thirty years later in 1973.

David Rockola invented everything from gaming devices, to parking meters, to vehicles, to juke boxes — what his is probably best know for.

It turns out that ROCKOLA was not just a snappy name for juke boxes, but it a snappy name for a prolific inventor who did far more than juke boxes.

October 7, 2024

On October 7, 1975, Ysidore M. Martinez received U.S. Patent No, 3,909,854 on a Knee Implant Prosthesis:

Ysidore, an amputee, revolutionized the prosthetic field by creating a prosthesis that was better at giving the wearer control of acceleration and deceleration, while simultaneously reducing pressure and friction for the wearer. This concept, a departure from trying to make prosthetics that faithfully mimicked the limb being replaced, is still used in prosthesis’ today.

October 6, 2024

On October 6, 2024, Chester F. Carlson a physicist, patent attorney, and inventor, received U.S. Patent No. 2,297,691 on Electrophotography – photocopying:

Chester did is initial work in a laboratory in Astoria, Queens, New York. The very first photocopied image was made there on October 22, 1928, which consisted of the date and place written by his laboratory assistant Otto Kornei, an out-of-work Austrian physicist.

The initial results thrilled Carlson, but Kornei was so discouraged, that within a year he left Carlson on cordial terms, dissolving his agreement with Carlson that would have given Kornei ten percent of Carlson’s future proceeds from the invention and rights in the inventions they had worked on together. Oops!

Carlson persisted, and eventually his ideas became the backbone of the Xerox Corporation. Xerox was a combination of the Greek words xeros (“dry”) and graphein (“writing”).  

October 5, 2024

On October 5, 1869, Fisher Spofford and Matthew Raffington received U.S. Patent 95,531 on Improvement in Water-Velocipedes:

Apparently, bicycling on water preoccupied the 19th century mind, because there are numerous

The fascination with bicycling on water even carried into the 20th Century:

October 4, 2024

On October 4, 1949, Harry Crooks, Mildred Rebstock, John Controulis, and Quentin Bartz received U.S. Patent No. 2,483,885 on Nitrophenyl Acyl Amido Alkane Diols:

Dr. Mildred “Millie” Rebstock was a researcher working for Parke, Davis & Company when she was charged with synthesizing a new antibiotic discovered in a culture of Streptomyces venezuela. Dr. Rebstock and her team found a way to fully synthesize this antibiotic, which allowed it to be economically manufactured, rather than producing it organically through fermentation.  This was the first time that an antibiotic has been synthesized. The ready availability of chloromycetin as a result of Rebstock’s Team’s work allowed its use to treat Rocky Mountain Spotted Fever and Typhoid. It is still used today as a secondary treatment for extreme cases of meningitis, cholera, and other bacterial diseases. After chloromycetin was linked to an increased risk of aplastic anemia, its use dropped off in developed nations, but it is still so widely used in developing nations that the World Health Organization has it on its list of Essential Medicines.